临床试验

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

NCT：NCT04796350 · RECRUITING

NCT编号NCT04796350

状态RECRUITING

开始日期2021-04-24

完成时间2029-04-01

SponsorAgNovos Healthcare, LLC (INDUSTRY)

First posted2021-03-12

Last updated2026-05-13

简要摘要

A randomized controlled trial to evaluate AGN1 to prevent secondary hip fractures in osteoporotic women undergoing treatment of index hip fractures. Up to 2400 subjects will be randomized between a treatment group and a control group. Subjects will be followed for a minimum of 5 years after undergoing hip fracture repair surgery.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。